Debt to Equity Ratio Chart

View Debt to Equity Ratio for GH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Debt to Equity Ratio Chart
Start Trial

Historical Debt to Equity Ratio Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 -7.614
March 31, 2026 -9.414
December 31, 2025 -17.22
September 30, 2025 -3.742
June 30, 2025 -4.368
March 31, 2025 -5.209
December 31, 2024 -9.567
September 30, 2024 -22.29
June 30, 2024 -831.44
March 31, 2024 19.73
December 31, 2023 8.531
September 30, 2023 5.950
June 30, 2023 4.652
March 31, 2023 -30.67
December 31, 2022 22.75
September 30, 2022 8.237
June 30, 2022 4.315
March 31, 2022 2.584
Date Value
December 31, 2021 2.130
September 30, 2021 1.916
June 30, 2021 1.717
March 31, 2021 1.594
December 31, 2020 0.6581
September 30, 2020 0.0431
June 30, 2020 0.0443
March 31, 2020 0.0523
December 31, 2019 0.0592
September 30, 2019 0.0085
June 30, 2019 0.0089
March 31, 2019 0.0156
December 31, 2018 0.0156
September 30, 2018 0.0301
June 30, 2018 0.028
March 31, 2018
December 31, 2017 0.0271

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
Natera, Inc. 0.1309
NeoGenomics, Inc. 0.5706
Quest Diagnostics, Inc. 0.8493
Labcorp Holdings, Inc. 0.7861
OPKO Health, Inc. 0.3362